Studies showed that circulating levels of GDF-15 are increased in patients with cardiovascular diseases, namely with chronic HF (236) and acute coronary syndrome (237), proving GDF-15 levels provide prognostic information and function as a biomarker of risk of death in these patients (236, 237). Here, GDF15 is linked to acute coronary syndrome.